Furthermore, dysregulation of insulin is involved in the pathogenesis of Alzheimer’s disease, where it is associated with lower levels of insulin in the CSF [60] and with amyloid-beta regulation [61,62,63,64]. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.